The Inevitable Amylin Buyout (AMLN, BMY, LLY, ALKS)
If there was a merger candidate which ever made sense in biotech and pharma it is Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN). News from Bloomberg is out that the company has rejected an ...Read Full Story »











